Necrosis and Angioinvasion Predict Adverse Outcome in Pancreatic Neuroendocrine Tumors After Curative Surgical Resection: Results of a Single-Center Series-Reference-Cited by-同舟云学术

Necrosis and Angioinvasion Predict Adverse Outcome in Pancreatic Neuroendocrine Tumors After Curative Surgical Resection: Results of a Single-Center Series

Published:2011-09-17 Issue:12 Volume:35 Page:2764-2772
ISSN:0364-2313
Container-title:World Journal of Surgery
language:en
Short-container-title:World J Surg

Author:

Demir Resit,Pohl Johann,Agaimy Abbas,Peros Georgios,Perrakis Aristoteles,Merkel Susanne,Hohenberger Werner,Klein Peter

Publisher

Springer Science and Business Media LLC

Subject

Surgery

Link

http://link.springer.com/content/pdf/10.1007/s00268-011-1262-9.pdf

Reference24 articles.

1. Lam KY, Lo CY (1997) Pancreatic endocrine tumor: a 22-year clinico-pathological experience with morphological, immunohistochemical observation and a review of the literature. Eur J Surg Oncol 23:36–42

2. Eriksson B, Oberg K (2000) Neuroendocrine tumors of the pancreas. Br J Surg 87:129–131

3. Moldow RE, Connelly RR (1968) Epidemiology of pancreatic cancer in connecticut. Gastroenterology 55:677–686

4. Kloppel G, Perren A, Heitz PU (2004) The gastroenteropancreatic neuroendocrine cell system and its tumors: the WHO classification. Ann N Y Acad Sci 1014:13–27

5. Capella C, Heitz PU, Hofler H et al (1995) Revised classification of neuroendocrine tumors of the lung, pancreas and gut. Virchows Arch 425:547–560

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Radiologic tumor border can further stratify prognosis in patients with pancreatic neuroendocrine tumor;Pancreatology;2024-08

2. Impact of Regional Metastasis on Survival for Patients with Nonfunctional Pancreatic Neuroendocrine Tumors: A Systematic Review;Annals of Surgical Oncology;2024-04-23

3. Practice patterns for reporting digestive system neuroendocrine neoplasms: results from a large, comprehensive international survey;Histopathology;2023-01-03

4. Spliceosomic dysregulation unveils NOVA1 as a candidate actionable therapeutic target in pancreatic neuroendocrine tumors;Translational Research;2023-01

5. Infiltrative Growth Predicts the Risk of Recurrence After Surgery in Well-Differentiated Non-Functioning Pancreatic Neuroendocrine Tumors;Endocrine Pathology;2022-12-24